Impact of the COVID-19 crisis on imaging in oncological trials
| Autor: | Frédéric Lecouvet, Laure Fournier, Nandita M. deSouza, Caroline Caramella, Joost J.C. Verhoeff, Christophe Deroose, Wolfgang G. Kunz, Bertrand Tombal, Laurence Collette, Marion Smits, Daniela E. Oprea-Lager, Lioe-Fee de Geus-Oei, Luc Bidaut, Egesta Lopci |
|---|---|
| Přispěvatelé: | UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale, UCL - (SLuc) Service d'urologie, UCL - (SLuc) Service de radiologie, Radiology and nuclear medicine, CCA - Imaging and biomarkers, Radiology & Nuclear Medicine |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
A300 Clinical Medicine Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Population MEDLINE 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Health care Pandemic medicine C741 Medical Biochemistry Radiology Nuclear Medicine and imaging Intensive care medicine education education.field_of_study business.industry Risk of infection C521 Medical Microbiology General Medicine A900 Others in Medicine and Dentistry C431 Medical Genetics B190 Anatomy Physiology and Pathology not elsewhere classified Radiology Nuclear Medicine and imaging 030220 oncology & carcinogenesis B990 Subjects Allied to Medicine not elsewhere classified business Disease transmission B820 Radiology |
| Zdroj: | Deroose, C M, Lecouvet, F E, Collette, L, Oprea-Lager, D E, Kunz, W G, Bidaut, L, Verhoeff, J J C, Caramella, C, Lopci, E, Tombal, B, de Geus-Oei, L-F, Fournier, L, Smits, M & deSouza, N M 2020, ' Impact of the COVID-19 crisis on imaging in oncological trials ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 9, pp. 2054-2058 . https://doi.org/10.1007/s00259-020-04910-y European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, no. 9, p. 2054-2058 (2020) European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer Verlag European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer-Verlag |
| ISSN: | 1619-7070 |
| Popis: | The unprecedented demand for hospital services during the SARS-CoV-2 (COVID-19) pandemic has dramatically reduced the capability for dealing with non-acute health needs, including cancer care [1, 2]. To alleviate burden on health care systems, including imaging and laboratory services, curtailment of non-COVID-19-related research activity has been necessary [3]. Measures that reduce hospital visits have been adopted to limit risk of infection and death, which is critical in a cancer population whose age and immunocompromised status increases their risk [4]. Imaging, however, requires hospital visits and close contact with staff and equipment; both are sources of disease transmission. Equipment used to image COVID-19 cases may retain virus on its surface for days [5, 6] unless disinfected. The need for social distancing and for disinfecting equipment substantially slows imaging workflow and reduces throughput. This article discusses the specific impact of pandemics such as SARS-CoV-2 on imaging in oncological trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |